Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Dominick J Angiolillo

Showing results (411-420 of 760) with videos related to

Pageof 76
Sort By:
The Journal of Invasive Cardiology|January 5, 2006
Prognostic impact of a chronic occlusion in a noninfarct vessel in patients with acute myocardial infarction and multivessel disease undergoing primary percutaneous coronary interventionRaul Moreno, Cesar Conde, Marie-Jose Perez-Vizcayno, et al.
Circulation|June 22, 2023
Considerations on the Management of Acute Postoperative Ischemia After Cardiac Surgery: A Scientific Statement From the American Heart AssociationMario Gaudino, George D Dangas, Dominick J Angiolillo, et al.
Frontiers in Pharmacology|July 9, 2021
Impaired Clinical Efficacy of Aspirin in Hypoalbuminemic Patients With Diabetes MellitusAngela Sciacqua, Francesco Andreozzi, Elena Succurro, et al.
Journal of Thrombosis and Thrombolysis|August 15, 2013
Pharmacodynamic effects of EV-077 in patients with diabetes mellitus and coronary artery disease on aspirin or clopidogrel monotherapy: results of an in vitro pilot investigationFabiana Rollini, Antonio Tello-Montoliu, Ronakkumar Patel, et al.
Catheterization and Cardiovascular Interventions : Official Journal of the Society for Cardiac Angiography & Interventions|September 25, 2008
Complete versus incomplete revascularization in patients with multivessel disease undergoing percutaneous coronary intervention with drug-eluting stentsCorrado Tamburino, Dominick J Angiolillo, Piera Capranzano, et al.
Clinical and Translational Science|November 24, 2019
Clinical Utility of Pharmacogene Panel-Based Testing in Patients Undergoing Percutaneous Coronary InterventionNihal El Rouby, Adel Alrwisan, Taimour Langaee, et al.
Clinical Pharmacokinetics|January 21, 2022
Pharmacokinetic and Pharmacodynamic Profile of a Novel Phospholipid Aspirin FormulationDominick J Angiolillo, Jayne Prats, Efthymios N Deliargyris, et al.
Circulation|January 31, 2007
Randomized comparison of a high clopidogrel maintenance dose in patients with diabetes mellitus and coronary artery disease: results of the Optimizing Antiplatelet Therapy in Diabetes Mellitus (OPTIMUS) studyDominick J Angiolillo, Steven B Shoemaker, Bhaloo Desai, et al.
Thrombosis and Haemostasis|December 11, 2012
Decrease in high on-treatment platelet reactivity (HPR) prevalence on switching from clopidogrel to prasugrel: insights from the switching anti-platelet (SWAP) studyJorge F Saucedo, Dominick J Angiolillo, Roger DeRaad, et al.
European Heart Journal. Acute Cardiovascular Care|July 12, 2015
Intracoronary vs intravenous bivalirudin bolus in ST-elevation myocardial infarction patients treated with primary angioplastyAlessandro Lupi, Andrea Rognoni, Chiara Cavallino, et al.
Pageof 76

Showing results (411-420 of 760) with videos related to

Sort By:
Pageof 76
The Journal of Invasive Cardiology|January 5, 2006
Prognostic impact of a chronic occlusion in a noninfarct vessel in patients with acute myocardial infarction and multivessel disease undergoing primary percutaneous coronary interventionRaul Moreno, Cesar Conde, Marie-Jose Perez-Vizcayno, et al.
Circulation|June 22, 2023
Considerations on the Management of Acute Postoperative Ischemia After Cardiac Surgery: A Scientific Statement From the American Heart AssociationMario Gaudino, George D Dangas, Dominick J Angiolillo, et al.
Frontiers in Pharmacology|July 9, 2021
Impaired Clinical Efficacy of Aspirin in Hypoalbuminemic Patients With Diabetes MellitusAngela Sciacqua, Francesco Andreozzi, Elena Succurro, et al.
Journal of Thrombosis and Thrombolysis|August 15, 2013
Pharmacodynamic effects of EV-077 in patients with diabetes mellitus and coronary artery disease on aspirin or clopidogrel monotherapy: results of an in vitro pilot investigationFabiana Rollini, Antonio Tello-Montoliu, Ronakkumar Patel, et al.
Catheterization and Cardiovascular Interventions : Official Journal of the Society for Cardiac Angiography & Interventions|September 25, 2008
Complete versus incomplete revascularization in patients with multivessel disease undergoing percutaneous coronary intervention with drug-eluting stentsCorrado Tamburino, Dominick J Angiolillo, Piera Capranzano, et al.
Clinical and Translational Science|November 24, 2019
Clinical Utility of Pharmacogene Panel-Based Testing in Patients Undergoing Percutaneous Coronary InterventionNihal El Rouby, Adel Alrwisan, Taimour Langaee, et al.
Clinical Pharmacokinetics|January 21, 2022
Pharmacokinetic and Pharmacodynamic Profile of a Novel Phospholipid Aspirin FormulationDominick J Angiolillo, Jayne Prats, Efthymios N Deliargyris, et al.
Circulation|January 31, 2007
Randomized comparison of a high clopidogrel maintenance dose in patients with diabetes mellitus and coronary artery disease: results of the Optimizing Antiplatelet Therapy in Diabetes Mellitus (OPTIMUS) studyDominick J Angiolillo, Steven B Shoemaker, Bhaloo Desai, et al.
Thrombosis and Haemostasis|December 11, 2012
Decrease in high on-treatment platelet reactivity (HPR) prevalence on switching from clopidogrel to prasugrel: insights from the switching anti-platelet (SWAP) studyJorge F Saucedo, Dominick J Angiolillo, Roger DeRaad, et al.
European Heart Journal. Acute Cardiovascular Care|July 12, 2015
Intracoronary vs intravenous bivalirudin bolus in ST-elevation myocardial infarction patients treated with primary angioplastyAlessandro Lupi, Andrea Rognoni, Chiara Cavallino, et al.
Pageof 76